期刊文献+

调节性T细胞抑制作用机制的研究进展 被引量:1

下载PDF
导出
摘要 调节性T细胞(Treg)对维持机体免疫动态平衡具有重要作用。不仅诱导产生自身免疫耐受,防止自身免疫疾病的发生,而且能够限制免疫防御中T、B细胞过度活化,避免造成组织损伤。最近研究发现,Treg可能导致效应性免疫细胞失活,降低机体对肿瘤和病原的免疫应答。尽管Treg可能通过调节免疫细胞活化、增值和分化及效应等多环节产生抑制作用,但其抑制机制仍未清楚。本文对近几年国外研究Treg可能的抑制作用机制的进展作一综述。
作者 王嘉军 张伟
出处 《微生物学免疫学进展》 2009年第4期62-65,共4页 Progress In Microbiology and Immunology
  • 相关文献

参考文献35

  • 1Sakaguchi S. Naturally arising Foxp3-expressing CD25^+ CD4^+ regulatory T cells in immunological tolerance to self and non-self [J]. Nat Immunol 2005, 6:345 - 352.
  • 2Shevach EM. Special regulatory T cell review: how i became a T suppressor/regulatory cell maven [ J ]. Immunology 2008, 123 : 3-5.
  • 3Sukiennicki TL, Fowell DJ. Distinct molecular program imposed on CD4^+ T cell targets by CD4^+ CD25^+ regulatory T cells [ J]. J Immunol 2006, 177:6952 - 6961.
  • 4Sojka DK, llughson A, Sukiennieki TL.et al. Early kinetic window of target T cell susceptibility to CD25^ + regulatory T cell activity [J]. J Immunol 2005, 175:7274 - 7280.
  • 5Sarween N, Chodos A, Raykundalia C, et al. Walker LS. CD4^+ CD2.5^+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion [J]. J Immunol 2004, 173:2942 - 2951.
  • 6Belkaid Y. Regulatory T cells and infection: a dangerous necessity [J]. Nat Rev Immunol 2007, 7:875 - 888.
  • 7Tadokoro CE, Shakhar G, Shen S, et al. Lafaille JJ, Dustin ML. Regulatory T cells inhibit stable contacts between CD4 ^+ T cells and dendritic cells in vivo [J]. J Exp Med 2006, 203:505 -511.
  • 8Tang Q, Adams JY, Tooley AJ, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice[J]. Nat Immunol 2006, 7:83 -92.
  • 9Cobbold SP, Adams E, Graca L, et al. Immune privilege induced by regulatory T cells in transplantation tolerance [ J]. Immunol Rev 2006, 213:239 - 255.
  • 10Mempel TR, Pittet MJ, Khazaie K,et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector diffcrentiation [ J]. Immunity 2006, 25 : 129 - 141.

同被引文献8

  • 1屠小卿,仲人前,范列英,朱烨,袁媛,季玲燕.自身免疫性肝病患者血清转化生长因子β_1测定的临床意义[J].检验医学,2004,19(5):427-428. 被引量:1
  • 2张莹,姚咏明,盛志勇.调节性T细胞研究进展[J].生理科学进展,2007,38(1):83-88. 被引量:17
  • 3Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of auto- immune hepatitis[J]. HepatoI, 1999,31 (5) : 929.
  • 4Heathcote EJ . Management of primary biliary cirrhosis . The American Association for the Study of Liver Disease practice guidelines[J]. Hepatology, 2000,31 (4) : 1005.
  • 5Tesmer LA, Lundy SK, Strkar S , et al. Thl7 cells human disease [J]. Immunol Rev, 2008,223 : 87.
  • 6Zhao L, Tang Y, You Z,et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression[J]. PLoS ONE,2011 ,6(4) :e18909.
  • 7Harada K, Shimoda S, Sato Y, et al. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogensis of cholongiopathy in primary biliary cirrhosis[J]. Clin Exp Immunol, 2008,157 : 261.
  • 8Yasumi Y, Takikawa Y, Endo R, et al. Interleukin-17 as a new marker of severity of acute hepatic injury[J]. Hepatol Res,2007, 37(4) :248.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部